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Oxyresveratrol (OXY) is a small molecule phytochemical which has been reported to have
important biological function. The aim of this study was to elucidate the gene expression
and biological pathways altered in MCF-7, breast cancer cells following exposure to OXY.
The cytotoxicity to different cancer cell lines was screened using MTT assay and then
whole gene expression was elucidated using microarray. The pathways selected were also
validated by quantitative PCR analysis, fluorometric and western blot assay. A total of 686
genes were found to have alteredmRNA expression levels of two-fold or more in the 50 μM
OXY-treated group, while 2,338 genes were differentially expressed in the 100 µM-treated
group. The relevant visualized global expression patterns of genes and pathways were
generated. Apoptosis was activated through mitochondria-lost membrane potential,
caspase-3 expression and chromatin condensation without DNA damage. G0/G1 and
S phases of the cell cycle control were inhibited dose-dependently by the compound.
Rad51 gene (DNA repair pathway) was significantly down-regulated (p < 0.0001). These
results indicate that OXY moderates key genes and pathways in MCF-7 cells and that it
could be developed as a chemotherapy or chemo-sensitizing agent.
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INTRODUCTION
Oxyresveratrol (OXY) (C14H12O4, M.W. 244.24 g/mol) is a naturally occurring polyphenol found to
be particularly concentrated in the heartwood of Artocarpus lakoocha Wall. ex Roxb (family:
Moraceae), an indigenous plant in Thailand (Radapong et al., 2020). The compound is in the group
of small molecule hydroxystilbenoids such as resveratrol, pterostilbene, gnetol and piceatannol,
which have been reported to possess various potent bioactivities such as cardioprotection,
neuroprotection, anti-diabetic properties, depigmentation, anti-inflammation, cancer prevention
and treatment (Akinwumi et al., 2018). However, several biological activities are unique to OXY
(antivirus and antihelminthics) (Galindo et al., 2011; Preyavichyapugdee et al., 2016). In
consideration of its chemical structure shown in Figure 1, which is similar to the well-known
antioxidant, resveratrol, it was hypothesized that it may also share similar anticancer properties to
resveratrol. Previously Chatsumpun et al. (2016) reported that OXY exhibited cytotoxicity to breast,
cervical and lung cancer cell lines. However, the precise mechanism involved in the modulation of
carcinogenesis remains to be elucidated.
The cancer hallmarks which identify cancer targets have been illustrated by Hanahan and
Weinberg (2011). The hallmarks involve defects in the regulation of cell proliferation and
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homeostasis, which include evading apoptosis, self–sufficiency
in growth signals, evading growth suppressor, tissue invasion
and metastasis, promoting inflammatory, autophagy, inducing
angiogenesis and genomic instability. The potential molecular
targets of an anticancer compound are illustrated in Figure 2.
Pro-apoptotics and apoptosis inducers that target the apoptosis
pathway are an effective way to treat to all types of cancer
(Pfeffer and Singh, 2018). OXY has been reported to induce the
intrinsic pathway of apoptosis in neuroblastoma cells (Rahman
et al., 2017). Rahman et al. (2017) have provided supporting
evidence of the apoptotic cell morphology changing and that
OXY–treated cells shrank and became rounded with membrane
blebbing and apoptotic vacuoles. The molecular targets of this
pathway included BAX and BCL–2 proteins, which triggered the
cascade proteins through mitochondrial apoptosis. Several
phytochemicals inhibit cancer cell proliferation by
modulating the genes that control several aspects of the cell
cycle. Cyclin–dependent kinases (CDKs) and E3 ubiquitin
ligases mainly play a crucial role throughout the process
(Duronio and Xiong, 2013). Resveratrol is found to cause
growth inhibition of human epidermoid carcinoma (A431)
cells via cell cycle arrest. Treatment with resveratrol
(1–50 μM for 24 h) causes an induction of WAF1/p21 that
inhibits cyclin D1/D2–CDK6, cyclin D1/D2– CDK4, and
cyclin E–CDK2 complexes, thereby imposing an artificial
checkpoint at the G1→S transition of the cell cycle (Ahmad
et al., 2001). OXY suppressed cell migration of Jurkat T cells in
response to stromal cell-derived factor 1 (SDF–1). The
mechanistic study indicated that OXY diminished CXCR4
–mediated T–cell migration via inhibition of the MEK/ERK
signalling cascade (Chen et al., 2013). OXY has been reported to
exhibit autophagy independently from apoptosis in
neuroblastoma cells. The molecular targets were mostly via
inhibition of PI3K/AKT/mTOR/pS6 signalling and activation
of p38 MAPK pathway (Rahman et al., 2017). OXY also showed
anti-inflammatory properties in murine macrophage cell line
RAW 264.7 by inhibiting the nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2) expression through down-
regulation of NF-kB binding activity (Chung et al., 2003).
Poly (ADP–ribose) polymerases (PARPs) are enzymes
involved in DNA–damage repair. Recently, inhibition of
PARP has emerged as a promising strategy for targeting
cancers with defective DNA–damage repair, (Livraghi and
Garber, 2015). The original concept of the activity of PARP
inhibitors was that they acted through synthetic lethality by
targeting the base excision repair pathway (BER) in
BRCA–deficient tumours. Therefore, disruption of the two
pathways led to cell death (Iglehart and Silver, 2009).
Resveratrol has been reported to show cleavage induction of
PARP1 (Demoulin et al., 2015). The compound also reduced the
FIGURE 1 | Chemical structure of OXY and resveratrol.
FIGURE 2 | Potential molecular targets of anti-cancer compounds adapted from Hanahan and Weinberg (2011).
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expression of genes in homologous recombination (HR) of the
DNA damage repair pathway including RAD recombinase 51
(RAD 51) in MCF-7 cells, enhancing the antiproliferative effect
of cisplatin (Leon-Galicia et al., 2018). RAD51 is an important
part of the mechanism and has been observed that the gene was
overexpressed in chemoresistant cancers ((Slupianek et al.,
2001; Hannay et al., 2007). Therefore, elucidation the of the
mechanism of action of OXY using a high throughput tool such
as microarray assay would allow greater understanding of how
cells respond to OXY.
This study aims to investigate the biological response to OXY
in MCF-7 cells focusing on cytotoxic and anti-cancer effects by
elucidating key genes and biological pathways involved.
MATERIALS AND METHODS
Cell Lines and Reagents
Human caucasian lung carcinoma cells (A–549), human
colorectal cancer cells (CACO–2), human caucasian hepatocyte
carcinoma cells (HepG2), human breast cancer cells (MCF-7),
Caucasian prostate adenocarcinoma cells (PC–3), Mouse
macrophage cells (RAW 264.7) and the two non-transformed
cell lines including Human foetal lung cells (MRC–5) and normal
human breast cells (MCF10A) were from the European collection
of authenticated cell cultures (ECACC) (Salisbury,
United Kingdom). A–549, CACO–2, HepG2, MCF-7, and
MRC–5 cells were maintained in Eagle’s minimum essential
medium (EMEM); RAW 264.7 cells were cultured in
Dulbecco’s modified eagle’s medium (DMEM); PC–3 were in
RPMI 1640 medium from Thermo Fisher Scientific (New York,
NY, United States) supplemented with 10% fetal bovine serum in
a 5% CO2 incubator at 37°C, while MCF10A cells were
maintained in DMEM/F12 medium supplemented with 5%
horse serum, 20 ng/ml epidermal growth factor, 0.5 mg/ml
hydrocortisone, 100 ng/ml cholera toxin, 10 μg/ml insulin and
1x pen/strep. OXY (>97%) was obtained from Sigma-Aldrich
(Buchs, Switzerland). The stock solution was freshly prepared by
dissolving in dimethyl sulfoxide (DMSO) and diluted in the
culture medium.
MTT Proliferation Assay
The cells were plated at a density of 7 × 103 cells per well in a
96-well plate to determine the cytotoxic effect of OXY. Cells
were incubated for 24 h and then treated with 1.56–200 µM
OXY for 48 h. After incubation, 0.5 mg/ml MTT [3-(4,5-
Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide]
was added to each well and incubated for 4 h followed by
200 µL DMSO. Absorbance was measured at 570 nm using
Clariostar microplate reader (MBG Labtech GmBH,
Ortenberg, Germany). The data were normalized to the
untreated (control) cells at 100% viability. The 50%
inhibitory concentration (IC50) was calculated using non-
linear regression (curve fit) analysis, GraphPad software and
Doxorubicin was used as a standard drug.
Gene Expression Profiling
MCF-7 cells were seeded at 2.5 × 105 cells/well in 6-well plates
for 24 h, then they were treated with OXY at the
concentrations of 0, 50, and 100 μM for 24 h. Total RNA of
each sample was extracted using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) pre-treated with on-column DNA digestion
with an RNase-free DNase kit (Qiagen, Hilden, Germany).
According to the manufacturer’s protocol, RNA was re-
suspended in 30 μL of nuclease-free water and stored at
−80°C until further analysis. The amount and quality of the
RNA samples were analyzed by NanoDrop 2000 (Thermo
Fisher Scientific, New York, NY, United States). The
samples were run on an Agilent RNA 6,000 Pico chip to
assess RNA integrity using the 2,100 Expert Software RNA
6,000 Pico kit through 2,100 Bioanalyzer instrument, which
was proceeded by the 2,100 Expert Software (Agilent
Technologies, Palo Alto, CA, United States).
Total RNA was processed using GeneChipTM WT PLUS
Reagents (Thermo Fisher Scientific, Palo Alto, CA,
United States) containing WT amplification kit module1, WT
amplification kit module2, Poly-A RNA Control Kit, WT
Terminal Labeling Kit and Hybridization Control Kit. The
samples were hybridized in biological triplicate to the Human
Clariom S arrays (a 400 format array) (Affymetrix Inc., Santa
Clara, CA, United States), following the manufacturer’s
recommendations.
Briefly, 100 ng of the pooled RNA was converted into the
first-strand cDNA. Second-strand cDNA synthesis was
followed by an in-vitro transcription to generate cRNA. The
cRNA products were used as templates for the second cycle of
cDNA synthesis, where deoxyuridine triphosphates were
incorporated into the new strand. The cDNA was then
fragmented using a uracil-DNA glycosylase and apurinic/
apirymidinic endonuclease. The fragments (50–70 mers)
were then labelled by means of a biotin-labelled
deoxynucleotide terminal addition reaction. The labelled
cDNA product was heated to 99°C and hybridized to each
array for 16 h at 45°C. Samples were washed with stain cocktail
and the array-holding buffer on the GeneChipTM Fluidics
Station 450 (Thermo Fisher Scientific, Palo Alto, CA,
United States).
A GeneChip 3000G scanner (Affymetrix Inc.) and the
Expression Console software (Affymetrix Inc.) were used to
obtain fluorescent signals and quality control data of the
scanned arrays. Signal intensities from each array were
analyzed using Partek Genomic Suite version 6.4 (Partek, St
Louis, MO, United States).
The microarray data were deposited at the NCBI GEO
database (GSE151139). The Transcriptome Analysis Console
(TAC) Software (Thermo Fisher Scientific, Palo Alto, CA,
United States) was used for the visualization of the expression
data in the biological pathways context. The data set was analyzed
using this tool and a gene expression fold change > 2 or < −2.
Ebayes Anova was used for statistical analysis with a
p-value < 0.05.
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Real-Time Reverse-Transcription
Polymerase Chain Reaction
cDNA was synthesed using QuantiTect Rev. Transcription Kit
(Qiagen, Valencia, CA, United States) following the
manufacturer’s protocol. Briefly, 2-µg template RNA was
added to the reverse-transcription master mix and then the
samples tubes were incubated at 42°C for 15 min. The cDNA
samples were tested in triplicate with quantitative PCR using a
QuantiTect SYBR Green PCR Reagents kit (Qiagen, Valencia,
CA, United States). Total 2 µL of each sample was mixed with
SYBR Green PCR Master Mix and 10x QuantiTect Primers
(Qiagen, Valencia, CA, United States). Real-time (RT-PCR) was
then performed following the manufacturer’s protocol in a
Rotor-Gene Q (Qiagen, Valencia, CA, United States). mRNA
ratios relative to the Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) housekeeping gene were calculated
for the standardization of gene expression levels. A melting
curve analysis was also performed to verify the specificity and
identity of PCR products. Finally, the products were run on
agarose gels to check the specificity of the PCR.
For selected genes, the data were analyzed using the equation
described by Livak and Schmittgen (Livak and Schmittgen, 2001)
as follows: the amount of target  2−ΔΔCt. The average ΔCt from
OXY untreated MCF-7 cells as a calibrator for each gene tested.
Data were presented as mean ± SD.
Quantification of Apoptotic Cells
Apoptosis was detected with the PE Annexin V apoptosis
detection kit I (BD Biosciences Inc, San Jose, CA, United
States). MCF-7 cells were seeded in 6–well plates and then
treated with OXY at different concentrations of 0, 25, 50 and
100 μM for 0, 3, 6, and 24 h. The cells were trypsinized and
washed twice with ice–cold phosphate-buffered saline (PBS),
and then cells were re–suspended at a concentration of 1 × 106/
ml cells in binding buffer. A total of 100 μL of the cell suspension
was transferred into a 2 ml micro centrifuge tube to which 5 μL
PE annexin V and 5 μL 7–amino–actinomycin D (a vital nucleic
acid dye) were added. The cells were gently mixed and incubated
in the dark for 15 min at room temperature. Finally, a 400 μL of
binding buffer was then added to each tube and the apoptotic
cells were quantified using the flow cytometer (BD Biosciences,
San Jose, CA) within 1 h. Cells that stained positive for PE
annexin V and negative for 7–amino–actinomycin D were
undergoing apoptosis; cells that stain positive for both PE
annexin V and 7–amino–actinomycin D were either in the
end stage of apoptosis, undergoing necrosis, or were already
dead; and cells that stain negative for both PE annexin V and
7–amino–actinomycin D were alive and not undergoing
measurable apoptosis.
Determination of Caspase–3 Expression
Induced by Oxyresveratrol
Active caspase–3 staining protocol was performed following
manufacturer’s instructions (PE active caspase–3 apoptosis kit,
BD biosciences, San diego, CA, United States). Total 5 × 105 cells
of MCF-7 treated with different concentrations of OXY were
harvested and transferred into 15 ml centrifuge tubes and then
the suspension was centrifuged at 300 × g for 5 min at 4°C. Cells
were washed twice with 1 ml ice–cold PBS and then re–suspended
in 0.50 ml BD Cytofix/Cytoperm™ solution. The cells were
incubated on ice for 20 min. After that the buffer was
removed, the cells were washed twice with 0.50 ml BD Perm/
Wash™ buffer at room temperature. Then, the cells were
re–suspended with 100 μL BD Perm/Wash™ buffer plus
antibody and incubated for 30 min at room temperature.
Finally, the cells were washed with 1 ml washing buffer and
re–suspended in 0.50 ml washing buffer. The cells were
maintained at 4°C until analysed by flow cytometer.
Mitochondrial Membrane Potential (ΔΨm)
Analysis by JC–1 Fluorescence
Cellular mitochondrial dysfunction can be reflected by the loss of
the mitochondrial membrane potential, which can be indirectly
measured by the fluorescent probe JC–1 using BD™ MitoScreen
Kit (BD Biosciences, Sandiego, CA, United States). The protocol
was followed according to the manufacturer’s instruction. Briefly,
MCF-7 cells treated with different concentrations of OXY were
harvested and transferred into 15 ml centrifuge tubes and then
the suspension was centrifuged at 300 × g for 5 min at 4°C. Then
the cells were re–suspended with 0.50 ml JC–1 working solution
and incubated at 37°C in a cell’s incubator for 15 min. The cell
pellet was washed twice with 1X assay buffer (2 and 1 ml,
respectively). Finally, the cells were re–suspended with 0.50 ml
1X assay buffer, then analysed by flow cytometry.
Nuclear Morphological Detection Using
Hoechst 33,342 Staining
The nuclear morphological changes of chromatin condensation
and chromosome fragmentation induced by OXY were examined
using hoechst 33,342 the staining was carried-out according to
the manufacture’s instructions. Briefly, the cells were treated with
different concentrations of OXY in 6–well plates for 24 h. The
10 mg/ml Hoechst stock solution was prepared and diluted with
PBS (1:2000). The medium was removed from each well and then
500 μL of the dye working solution was added. The plate was
incubated in the cell incubator for 10 min. Afterwards, the cells
were washed with 1 ml PBS for three times. The cells were viewed
under fluorescence microscope (Olympus, Hamburg, Germany).
The mode of cell death was then determined in terms of distinct
morphological changes, including membrane blebbing, nuclear
and cytosolic condensation and nuclear fragmentation in the
treated group compared to the untreated cells which served as the
control.
Measurement of DNA Damage by Comet
Assay
The comet assay was performed under alkaline conditions. Cells
were seeded in 6–well tissue–culture plates. They were treated
with 50 and 100 µM OXY. After 24 h of exposure with OXY or
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100 µM H2O2 for 4 h as the positive control, cells were collected
by trypsinization, washed with PBS and resuspended in ice–cold
PBS. 10 μL of the resuspended cells was mixed with 100 μL of low
melting point agarose at 37°C and spread the suspension over the
well with the pipette tip. The slides were placed at 4°C in the dark
until gelling occurred and then immersed in pre–chilled lysis
buffer at 4°C. After 60 min incubation, the buffer was aspirated
and replaced with pre–chilled alkaline solution for 30 min at 4°C.
After lysis and unwinding, the slides were placed in a horizontal
electrophoresis tank filled with freshly prepared alkaline
electrophoresis buffer. The electrophoresis was run for 25 min
at 15 V and 300 mA. After electrophoresis, the slides were
transferred to pre–chilled distilled water and immersed for
2 min, aspirated and repeated twice. The final water rinse was
aspirated and replaced with cold 70% ethanol for 5 min.
Thereafter, the slides were allowed to air dry and 100 μL/well
of diluted Vista Green DNA dye was added to each slide for
15 min in the dark at room temperature for DNA staining. DNA
migration was observed using fluorescence microscope at a
magnification of 10X (Leica Microsystems CMS GmbH,
Germany).
Cell Cycle Analysis Using Flow Cytometry
Cell cycle analysis was conducted by BD Cycletest™ Plus kit (BD
biosciences, San Diego, CA, United States) using propidium
iodide as a DNA stain to determine DNA content in the cells.
The effect of OXY treatment on the cell cycle was determined by
flow cytometry as described by the manufacturer’s instruction.
Briefly, MCF-7 cells were seeded at 2.5 × 105 cells/well in 6–well
plates. MCF-7 cells were treated with OXY at the concentration of
25, 50, and 100 μM for 3, 6 and 24 h. Cells were trypsinized with
300 μL of 0.25% trypsin solution for 3 min in the cell incubator.
Total 200 μL of fetal bovine serum was added and then all of the
cell suspension was transferred into a 15 ml centrifuge tube. The
suspension was centrifuged at 300 rcf for 5 min. The supernatant
was discarded, the cell pellet was re–suspended with 1 ml buffer
solution (contains sodium citrate, sucrose, and DMSO). The cells
were centrifuged and re–suspended one more time and then
counted using a hemacytometer for 5 × 105 cells. Cells were
frozen in the freezer (–80°C) for PI staining. The cell suspensions
were thawed in water bath, centrifuged at 400 g for 5 min at room
temperature (20–25°C). All the supernatant was carefully
decanted. A 250 μL of solution A (trypsin buffer) was added
to each tube and gently mixed by tapping the tube, incubated for
10 min at room temperature. Afterwards, a 200 μL of solution B
(trypsin inhibitor and RNase buffer) was added to each tube and
gently mixed by tapping the tube by hand, and incubating for
10 min at room temperature. Finally, a 200 μL solution C (PI stain
solution) was added to each tube and incubated for 10 min in the
dark on ice or in the refrigerator (2–8 °C) until analyzed by flow
cytometer. A total number of 1 × 104 cells was subjected to cell
cycle analysis using the flow cytometer.
Western Blot
Cells were seeded at 2.5 × 105 cells/well on 6-well dishes and
allowed to adhere overnight. Cells were then treated with OXY at
the concentrations of 50 and 100 µM for 24 h and then washed
twice with ice-cold PBS. The cells were then lyzed in lysis buffer
(protease inhibitor cocktail) left on ice for 5 min then, transferred
to centrifuge tubes, sonicated for 30 s with 50% pulse and then
centrifuged at ∼14,000 ×g for 15 min to pellet the cell debris. The
supernatants were then collected, and protein concentrations
determined by Bradford assay (Bio-Rad, Richmond CA,
United States). An equal amount of protein sample (20 μg)
was resolved by a volume of 2x Laemmli sample buffer, then
boiled for 5 min 7.5% Mini-PROTEAN® TGX Stain-Free™
protein gels (Bio-Rad, Richmond, CA, United States) were
used and run at 180 V for 1 h. Protein transfer was achieved
using Trans-Blot® Turbo™ mini PVDF transfer packs (Bio-Rad,
Richmond, CA, United States). Proteins were transferred onto
PVDF membrane at 1.3 A for 7 min. Membranes were then
blocked with 5% skim milk/TBST for 1 h and then probed with
the indicated primary antibody overnight at 4°C and then blotted
with appropriate horseradish peroxidase-conjugated secondary
anti-rabbit antibody. Visualization was performed using an
enhanced chemiluminescence kit (BioRad Inc., Hercules, CA,
United States) with Clarity™ Western ECL Substrate. Protein
level was normalized to the matching densitometric value of the
internal control β-actin.
Statistical Analysis
Results of MTT assays were expressed as mean ± standard error.
Significant differences in genes in WikiPathways were detected
using Fisher’s Exact Test. Statistical significance was assessed by
One-way analysis of variance followed by Dunnett’s test or the
unpaired t-test using GraphPad Prism 9 (GraphPad Software, La
Jolla, CA, United States).
RESULTS
MTT Cytotoxicity
MTT assay was used to analyze the viability of the cells treated
with different concentrations of the compound for 48 h. The
total DMSO concentration in the cell culture medium did not
exceed 0.5% which was found not to affect the cell growth or
viability of the cells. After 48 h of treatment, OXY significantly
inhibited cell growth and viability in a dose-dependent manner
to MCF-7, HepG2, PC–3, RAW 264.7 and A–549 cells with the
IC50 values of 30.64 ± 4.79, 104.47 ± 0.82, 109.35 ± 9.63,
115.95 ± 11.28, and 148.63 ± 4.48 µM, respectively. Whereas,
TABLE 1 | Inhibitory concentration (IC50, µM) of OXY to the cells.
Oxyresveratrol (µM) Doxorubicin (µg/ml)
A–549 148.63 ± 4.48 0.54 ± 0.02
CACO–2 >200 3.27 ± 1.06
HepG2 104.47 ± 0.82 0.84 ± 0.08
MCF–7 30.64 ± 4.79 0.21 ± 0.07
PC–3 106.90 ± 8.63 3.08 ± 0.48
RAW 264.7 115.95 ± 11.28 0.21 ± 0.07
MRC–5 >200 0.37 ± 0.01
MCF10A >200 NA
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the compound showed no toxicity to CACO–2, MCF10A and
MRC–5 (IC50 > 200 µM). IC50 values of OXY and doxorubicin
are shown in Table 1.
Effect of Oxyresveratrol on the Human
Breast Cancer Cells Gene Expression
Profiles
Global expression patterns of genes and pathways were obtained
using microarray technology and data analysis software. Gene
expression changes occurring as a consequence of the exposure
of MCF-7 cells to 50 or 100 µM OXY for 24 h was performed as
described in the materials and methods section. The number of
differentially expressed genes under both conditions compared
to the control group were observed. The cellular pathways in
which these differentially expressed are found were shown in
Figure 3.
A total of 686 genes were differentially expressed in the 50 µM-
treatment group; with 262 genes being upregulated and 424
downregulated. Total 2,338 genes were differentially expressed
in the 100 µM-treated groups; among these, 907 were upregulated
and 1,431 were downregulated (showed in the Supplementary
Materials). WikiPathways (wikipathways.org), a biology
community maintained website that displays biological
FIGURE 3 |Gene ontology-based biological process pathways altered by OXY in MCF-7 breast cancer cells. Differentially expressed genes in MCF-7 cells treated
with 50 µM (A) or 100 µM (B) of OXY for 24 h. To determine the biological process and pathways involved, the list of significantly upregulated and downregulated genes
was analyzed using Fisher’s Exact Test, and then analyzed using WikiPathways.org.
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pathways, was utilized to identify pathways and the functions of
genes altered by OXY treatment in MCF-7 cells.
From this analysis, it was found that the first 20 most affected
pathways (arranged from significant values in the 100 μM-OXY
treatment) followingOXY treatment were associated with cell cycle
control, apoptosis and DNA repair, as well as the senescence and
autophagy processes. It was also noted that the majority of the
genes in cell cycle control and DNA repair were down regulated,
while those in apoptosis and autophagy were up regulated.
Among these, the most dramatically affected pathways were
that of cell cycle control. At both 50 and 100 μM OXY, the
expression of DNA-damage-inducible, alpha (GADD45A) and
cyclin-dependent kinase inhibitor 1A (p21, CDKN1A) were up
regulated. Whereas, cyclin-dependent kinase 2 (CDK2), E2F
transcription factor one (E2F1) were down regulated (Figure 4).
Validation of Differentially Expressed Genes
To validate the microarray results, the mRNA expression of
selected genes involved in the regulation of cell cycle, apoptosis,
DNA repair and autophagy (CDK2, CDK4, BCL-2, E2F1, BAX,
CDKN1A, GADD45A, CASP8, DIABLO, FAS, JUNB, MAPK8,
TNFRSF10B, PARP1, BRCA1, RAD51, AKT1, ESR1,
FIGURE4 |Cell cycle control pathway integrating expression data for MCF-7 cells treated with 100µMOXY for 24 h. Genes labelled in green are up regulated and in
red are down regulated.
FIGURE 5 | Relative quantity of mRNA expression from MCF-7 cells
treated with OXY. Validation of selected genes differentially expressed in MCF-7
cells treated for 24 h with 50 or 100 µM of OXY vs. control data set. Statistical
analysis was carried out using unpaired t test (*p < 0.5, **p < 0.05 and
****p < 0.0001).
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FIGURE 6 | Induction of apoptosis by OXY in MCF-7 cells determined using flow cytometry. Bar graphs showing the percentage of MCF-7 cells in apoptosis, live
cells and dead cells when treated with 0, 25, 50 and 100 μM OXY for 24 h and camptothecin (CTC) for 4 h and then subject to flow cytometric analysis. Data are the
mean ±SEMof three independent experiments. Statistical analysis was carried out using One-way ANOVA analysis of variance followed by Dunnett’s test. The significant
difference was compared relatively to control (*p  0.037, **p  0.003 and ****p < 0.0001).
FIGURE 7 | Caspase–3 expression in MCF-7 cells following exposure to various concentrations of OXY for 24 h and camptothecin (CTC) for 4 h. The cells were
stained with anti–active caspase–3 and analyzed by flow cytometry. Data are the mean ± SD of three experiments. Statistical analysis was carried out using One-way
ANOVA analysis of variance followed by Dunnett’s test. The significant difference was compared relatively to the control (****p < 0.0001).
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GABARAPL2, MAP1LC3B, SQSTM, and TP53) was confirmed
using RT-qPCR. Triplicates were performed for each gene. In all
cases, the RT-qPCR data confirmed those obtained by 50 and
100 μM-OXY treated array analyses (Figure 5). The genes
involving cell cycle control, DNA replication, apoptosis,
senescence and autophagy in cancer pathways including CDK4,
E2F1, Bax, CDKN1A, GADD45A, FAS, GABARAPL2, and SQSTM
were significantly upregulated. Whereas, the genes in DNA repair
pathway including PARP1, BRCA1, and RAD51 were significantly
downregulated compared between the two doses treated.
Quantification of Apoptosis
Apoptosis induction by OXY in the cells was determined. The
apoptotic cells expressing PS on their cell membranes were
detected using Annexin V conjugated with PE. OXY induced
apoptosis in MCF-7 cells dose–dependently at the concentrations
tested of 25, 50 and 100 µM compared to the untreated control
(0 µM) exhibiting the PE Annexin V fluorescence percentage of
3.14 ± 0.37, 5.74 ± 0.53 and 11.69 ± 1.15%, respectively. Following
24 hours of treatment; the cells treated with OXY 25 µM became
apoptotic, while those treated with OXY 50 and 100 µM were
significantly different from the controls. These results illustrate
that most of the cells treated with 50 and 100 µM OXY within
24 h underwent apoptosis and as a consequence died (Figure 6).
Caspase–3 Expression
The apoptotic executioner protein, caspase 3, which made the
cells cytomorphological charateristic change was also
determined using anti-active caspase–3 conjugated with PE.
MCF-7 cells treated with different concentrations of OXY at
doses of 25, 50 and 100 µM for 24 h showed a dramatically
changed amount of caspase–3 expression on cell membranes
compared to the control; more than 98% of the population was
caspase–3 positive in all doses treated, while the cell population
of the caspase–3 negative decreased proportionally. All
treatments were significantly different compared with the
control (Figure 7).
Mitochondrial Membrane Potential (ΔΨm)
Mitochondrial dysfunction is associated with changes in ΔΨm.
Mitochondrial membrane depolarization was measured by JC-
1. At high ΔΨm, JC-1 the cationic lipophilic probe
spontaneously formed J-aggregates with red fluorescence. On
the other hand, at low ΔΨm, depolarized mitochondria, JC-1
stayed monomeric resulting in low or no fluorescence signal. As
the concentration of OXY increased, the mean values of FL2
FL1−1A gating P4 decreased (normal membrane potential).
These results indicate that the mitochondrial membrane was
depolarized in a dose-dependent manner. MCF-7 cells lost
mitochondria membrane potential dose–dependently
following exposure to several concentrations of OXY, which
caused the cells to undergo apoptosis. 24–h treatment was
found to cause membrane potential loss to a significant
degree compared to the untreated control; 4.15 ± 0.08,
4.77 ± 2.56 and 11.47 ± 2.75% for 25, 50 and 100 µM–OXY,
respectively (Figure 8).
FIGURE 8 |Mitochondrial membrane potential of MCF-7 cells following exposure to various concentrations of OXY for 24 h and camptothecin (CTC) for 4 h. The
cells were stained with JC–1 and analyzed by flow cytometry. Data are the mean ± SD of three experiments. Statistical analysis was carried out using One-way ANOVA
analysis of variance followed by Dunnett’s test. The significant difference was compared relatively to control (***p < 0.001 and ****p < 0.0001).
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Nuclear Morphological Detection
MCF-7 cells were investigated for nuclear and chromatin
changes following treatment with OXY. The pictures of
chromatin changed are shown in Figure 9A. MCF-7 cells
were observed to have undergone chromatin condensation at
all doses used.
DNA Damage by Comet Assay
MCF-7 cells treated with OXY were investigated for DNA
damage as shown in Figure 9B. The cells treated with 50 and
100 µM of OXY for 24 h did not display DNA damage. OXY at
the effective doses did not cause damage to DNA in MCF-
7 cells.
Cell Cycle Analysis
The cell cycle arrest was also analyzed by treating the cells with
different doses of OXY. The results in Figure 10 show that the
compound decreased DNA content dose-dependently in G0/G1
phase of the cell cycle at 24 h. Compared with the untreated
control (0 µM), 25, 50 and 100 µMOXY decreased the percentage
of the cell population from 85.43 ± 0.34 to 75.39 ± 0.75, 72.34 ±
0.82, and 62.27 ± 0.68%, respectively. S phase also significantly
decreased from 19.37 ± 0.09 to 19.35 ± 0.48, 16.47 ± 0.63, and
14.66 ± 0.57%, respectively. whereas G2/M phase was induced
from 3.52 ± 0.11 to 4.50 ± 0.46, 3.68 ± 0.17, and 7.40 ± 0.38%,
respectively during the time incubated. These results indicate that
OXY arrested G0/G1 and S phases of the cell cycle.
Western Blot Analysis
Protein bands of the expected size corresponding to RAD51,
PARP1 and BRCA1 in the whole-cell extracts treated with
different doses of 50 and 100 µM OXY were observed
compared to untreated controls (Figure 11). The protein
expression of RAD51 (ratio to ACTB) was significantly
different relative to control (0.54 ± 0.15 to 0.33 ± 0.06, and
0.25 ± 0.02), respectively. While PARP1 and BRCA1 expression
decreased slightly, but not significantly compared to the control.
These proteins were also evaluated for changes in expression in
MCF10A cells following treatment with OXY, but expression
levels of the proteins of interest were not found to be significantly
different from the controls (data not shown).
DISCUSSION
Microarray-based techniques including GeneChip™ are high-
throughput technologies for genetic exploration. These
technologies have been developed as a single platform which
provides extensive information on gene networks and functions
on drug efficacy and toxicity (Taylor et al., 2005). Over the years,
this kind of platform has been extensively implemented to
evaluate the effect of OXY and derivatives, especially
resveratrol on several cancerous cells such as multiple
myeloma and colorectal cancer cells (Geng et al., 2018; Lee
et al., 2018). However, OXY, in this study is also reported to
FIGURE 9 | MCF-7 nuclei staining by Hoechst 33,342 (A) photomicrographs of stained DNA of MCF-7 cells (alkaline comet assay) (B) apoptosis detection
following treatment with different concentrations of OXY for 24 h and 100 µM H2O2 for 4 h.
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demonstrate selective toxicity towards MCF-7 cells compared to
MCF10A cells and others. The exposure time between the cells
and OXYwas reduced to 24 h (IC50 for MCF-7 cells  368.37 µM)
in microarray and qPCR analysis because the experiment was
designed to analyze the gene expression of the main molecular
effects at the early stage (Li and Sarkar, 2002). Amongst the OXY-
modulated genes observed in MCF-7 cells, the genes that were
significantly changed (mostly downregulated) were involved in
cell cycle control, DNA replication and DNA synthesis.
Apoptosis is a vital component of cellular processes
moderating life and death of cells and therefore is of great
therapeutic potential (Kruidering and Evan, 2000). Moreover,
Apoptosis, which can cause damage to DNA, is the central
mechanism of chemotherapeutics and most plant–derived
anticancer drugs (Cragg and Pezzuto, 2016). OXY induced
apoptosis through both intrinsic and extrinsic pathways. It is
possible in consideration of the results reported here that OXY
decreased the expression of anti-apoptotic proteins such as B-cell
lymphoma 2 (BCL-2) and increased pro-apoptotic proteins like
BAX and BCL-2 -antagonist/killer-1 (BAK). It is then possible
that DIABLO and cytochrome c released, activated apoptotic
peptidase activating factor 1 (APAF1) forming apoptosomes,
which led to the loss of mitochondrial membrane potential.
On the other hand, the results reported here suggest that the
extrinsic apoptotic pathway may have been initiated by OXY
through Fas cell surface death ligand/receptor (FASL/FASR) and
tumour necrosis factor-alpha/receptor (TNF-α/TNFR1),
activating CASP8, with the subsequent activation of CASP3.
Notably, OXY has been previously reported to induce the
intrinsic pathway of apoptosis in neuroblastoma cells (Rahman
et al., 2017).
CDK2, CDK4 expression plays an important role in G1-S
phase checkpoint control normally working together with cyclin
E as a complex protein. This complex increases the synthesis of
histone proteins and DNA replication (Caruso et al., 2018).
Therefore, the G0/G1 and S phases of cell cycle were arrested.
CDK2 is also inhibited by CDKN1A, which represents a major
target of p53 activity. Interestingly, TP53 remained unchanged in
response to the treatment, which was consistent to the previous
study reported that OXY moderated p53-independent S phase
arrest, ROS–independent apoptosis in neuroblastoma cells
(Rahman et al., 2017). The results here illustrate that OXY
induced apoptosis in the cells but did not activate TP53,
which was responsible for the DNA damage. However, p53-
independent upregulation of CDKN1A may be induced by some
genes in cell cycle, apoptosis or senescence and autophagy in
cancer pathways (Aliouat-Denis et al., 2005). Recently, CDK
inhibitors have been investigated as a possible
chemotherapeutic (Wood et al., 2019). OXY significantly
decreased the expression of CDK4 and E2F1, which
subsequently conducted cell cycle arrest.
OXY-treated MCF-7 cells induced the expression of
autophagic genes including microtubule-associated protein one
light chain 3 beta (MAP1LC3B), sequestosome 1 (SQSTM1) and
FIGURE 10 | Effect of OXY on cell cycle distribution in MCF-7 cells determined using flow cytometry. The histograms showing the numbers of cells in different
phases after MCF-7 cells were treated with 25–100 μM OXY for 3–24 h and then subjected to flow cytometric analysis. Data are the mean ± SD of three experiments.
Statistical analysis was carried out using One-way ANOVA analysis of variance followed by Dunnett’s test. The significant difference was compared relatively to control
(*p  0.0134, ***p  0.002 and ****p < 0.0001).
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GABA(A) receptor-associated protein like 2 (GABARAPL2).
Autophagy or self-eating is an evolutionarily conserved
catabolic pathway in eukaryotes playing a significant role in
the recycling of cellular components as part of a housekeeping
function with Beclin1 and Atg5 reported to play important roles
(Bilir et al., 2002). Autophagy-mediated cell death can be the
starting process of apoptosis, and blocking caspase activity can
cause a cell to enter autophagy cell death instead of apoptosis
(Lockshin and Zakeri, 2004). OXY has been previously reported
to be capable of inducing neuroblastoma cell death by autophagy
via the PI3K/AKT/mTOR pathway (Rahman et al., 2017).
OXY dose-dependently mediated down regulation of DNA
repair gene expression (PARP1, RAD51 and BRCA1) in MCF-7
cells. The significantly down-regulated expression of RAD51 by
OXY may be the key mechanism by which OXY mediates its
anticancer effect in consideration of RAD51 being overexpressed in
a variety of cancer cells (Raderschall et al., 2002; Hannay et al.,
2007; Klein, 2008). The principle of inhibiting DNA repair genes
has been proposed for cells that carry mutations in the breast
cancer susceptibility genes BRCA1 or BRCA2 as a possible cancer
drug target (Farmer et al., 2005). Previously Walsh (2015) reported
that a deficiency in PARP or BRCA alone had no impact on cancer
cell viability, but a deficiency in both leads to a lethal effect on
cancer cells. The western blot analysis presented here demonstrates
that OXY inhibited the protein expression of RAD51 and slightly
decreased the expression of PARP1 and BRCA1. Moreover, the
inhibition of RAD51 also enhanced cytotoxicity and apoptosis
induction in cancer stem cells (Ruiz et al., 2018) Oxyresveratrol’s
property of apoptosis activation, cell cycle arrest, cell senescence
and autophagy including the implication of inhibiting RAD51may
be able to facilitate an increase in the efficacy of commonly used
chemotherapeutics.
CONCLUSION
In this research report, we clearly demonstrate that OXY regulates
the expression of various genes, which have important roles in
carcinogenesis-associated pathways. OXY enhanced the
apoptosis cascade through both extrinsic and intrinsic
pathways. OXY also decreased the expression of CDK2, CDK4
and E2F1, affecting the initial stage of the cell cycle (G1-S phase).
More interestingly, the compound induced a down-regulation of
genes and protein activities involved in DNA repair, including
RAD51 and PARP1. These results indicate that OXY may be
utilized to overcome drug resistance and enhance the efficacy of
chemotherapy drugs.
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